For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220412:nRSL1667Ia&default-theme=true
RNS Number : 1667I Induction Healthcare Group PLC 12 April 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Purchase of Shares by Director
Induction Healthcare (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, announces that Andy Williams,
Non-Executive Director, has today purchased 179,484 ordinary shares in the
Company at 51.5 pence and following this Mr Williams holds 889,968 ordinary
shares, representing 0.97 per cent. of the Company's current issued share
capital.
In the announcement released at 7.00 a.m. today, Mr Williams' shareholding was
incorrectly shown as 610,484 shares when it should have been 710,484 shares.
Similarly, Dr Hugo Stephenson's shareholding was shown as 2,226,273 shares
when it should have been 2,256,273 shares.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
(mailto:induction@walbrookpr.com)
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com (mailto:induction@walbrookpr.com)
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407 804 654
About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)
Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - enabling a more flexible,
efficient and positive experience for the communities they serve. Purpose
built for integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even greater when
integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.
The information set out below is provided in accordance with the requirements
of Article 19(3) of the EU Market Abuse Regulation No 596/2014
1. Details of the person discharging managerial responsibilities / person closely
associated
a. Name Andy Williams
2. Reason for the notification
a. Position/status Non-Executive Director
a. Initial notification /Amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name Induction Healthcare Group plc
b. LEI 213800RY96GCZQW5TP19
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Financial instrument, type of instrument Ordinary shares of 0.5 pence each
Identification code
GB00BJ0M3545
b. Nature of the transaction Purchase of Ordinary Shares
c. Price(s) and volume(s) 51.5 pence
179,484 Ordinary Shares
d. Aggregated information N/A
·Aggregated volume
·Price
e. Date of the transaction 12 April 2022
f. Place of the transaction London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHITMITMTABBLT